Stock DRREDDY DR. REDDY'S LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Dr. Reddy's Laboratories Limited

Equities

DRREDDY

INE089A01023

Market Closed - Bombay S.E.
Other stock markets
 06:23:02 2024-04-19 am EDT 		5-day change 1st Jan Change
5,943 INR -0.28% Intraday chart for Dr. Reddy's Laboratories Limited -3.52% +2.50%
12:32pm Dr. Reddy's Labortories Launches Care Plan for IBS Patients MT
Apr. 18 India's Biocon developing its own version of Wegovy, clinical trial likely next year RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Dr Reddy Laboratories : . Reddy's launches Condition Management programme ‘DailyBloom™ IBS’, India’s first-ever digital integrated care plan to manage Irritable Bowel Synome - Form 6-K
PU
Dr. Reddy's Labortories Launches Care Plan for IBS Patients
MT
India's Biocon developing its own version of Wegovy, clinical trial likely next year
RE
Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Remain Flat in Wednesday Trading
MT
Financial, Telecoms Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Sharply Lower Tuesday
MT
Dr Reddy Laboratories : . Reddy's Investor Presentation - Sep 2023
PU
Dr. Reddy's Launches Migraine Management Device Nerivio in Germany
MT
Dr Reddy Laboratories : . Reddy’s launches ug-free migraine management device Nerivio® in Europe following successful launch in India - Form 6-K
PU
Dr. Reddy's Launches Migraine Management Wearable in Germany
MT
Dr Reddy Laboratories : Press Release Nerivio (Global) - Dr. Reddy's launches Nerivio in Europe
PU
Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment
AQ
Asian Equities Traded in the US as American Depositary Receipts Start Week on Strong Note in Monday Trading
MT
Sector Update: Health Care Stocks Rise Late Afternoon
MT
Dr. Reddy's Laboratories, Bayer Collaborate to Distribute Second Brand of Heart Failure Drug in India
MT
Asian Equities Traded in the US as American Depositary Receipts Nudge Higher in Friday Trading, End Week Lower
MT
Dr Reddy Laboratories : Bayer and Dr. Reddy’s sign a marketing and distribution agreement for second brand of Vericiguat™ in India - Form 6-K
PU
Bayer and Dr. Reddy's Sign A Marketing and Distribution Agreement for Second Brand of Vericiguat in India
CI
Dr Reddy Laboratories : Press Release_Bayer and Dr. Reddy’s sign a marketing and distribution agreement for second brand of Vericiguat™ in India
PU
Asian Equities Traded in the US as American Depositary Receipts Rebound in Early Wednesday Trading
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DRREDDY Stock
  4. News Dr. Reddy's Laboratories Limited